InsiderTrades

Form 4 for ISRG Intuitive Surgical

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-13 · accession 0001035267-23-000023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-14 2023-02-13 ISRG MOHR MARSHALL Executive VP Gbl Business S M - OptEx $63.25 +54.0K 54.0K New +$3.42M
D 2023-02-14 2023-02-13 ISRG MOHR MARSHALL Executive VP Gbl Business S S - Sale+OE $245.61 -33.2K 20.8K -62% -$8.17M
D 2023-02-14 2023-02-13 ISRG MOHR MARSHALL Executive VP Gbl Business S M - OptEx $0.00 -54.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-13 M A 54,000 $63.25 54,000 D — —
2 Common Common Stock 2023-02-13 S D 33,249 $245.61 20,751 D — — (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $245.10 to $246.47 as follows: 29,736 shares sold at $245.10 to $246.10; and 3,513 shares sold at $246.15 to $246.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3 Derivative Non-Qualified Stock Option (right to buy) 2023-02-13 M D 54,000 $0.00 0 D $63.25 · — to 2023-02-15 54,000 Common Stock (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter.